Rare diseases
Investigational molecules
Locations
Study on Long-Term Safety and Efficacy of Ocrelizumab for Patients with Multiple Sclerosis
GermanyStudy on Pembrolizumab for Patients with High-Risk Stage III Melanoma After Surgery
GermanyStudy on the Effectiveness and Safety of Ianalumab for Patients with Active Sjögren’s Syndrome
GermanyStudy of iberdomide alone or with drug combinations for patients with multiple myeloma: testing safety and effectiveness of different doses
GermanyStudy on the Effectiveness and Safety of AC102 Injection vs. Oral Prednisolone for Patients with Sudden Hearing Loss
GermanyStudy Comparing Trastuzumab Deruxtecan and Trastuzumab Emtansine for Patients with High-Risk HER2-Positive Breast Cancer with Residual Disease After Initial Treatment
GermanyStudy on Trastuzumab Deruxtecan for Patients with Advanced Non-Small Cell Lung Cancer with HER2 Mutations
GermanyStudy of ianalumab versus placebo in adults with warm autoimmune hemolytic anemia who failed previous treatment
GermanyStudy on the Safety and Effects of ICT01, Aldesleukin, and Pembrolizumab for Patients with Advanced Solid Tumors
GermanyStudy on the Safety of Tirbanibulin and Diclofenac Sodium for Adults with Actinic Keratosis on the Face or Scalp
GermanyStudy on Golcadomide and R-CHOP Drug Combination for Patients with Untreated High-risk Large B-cell Lymphoma
GermanyStudy of ribociclib combined with hormone therapy for patients with early-stage hormone receptor-positive, HER2-negative breast cancer
GermanyTell us about your condition – we search every trial in Europe and connect you with the right site.
